Heart disease is often associated with the heart and arteries, but its effects extend far beyond the cardiovascular system.
D Molecular Therapeutics (NASDAQ:FDMT) and the U.S. FDA have reached agreement on a phase 3 trial design for diabetic macular ...
Discover how your diet can improve vision health with essential nutrients, carotenoids, and food pairings for long-term eye ...
4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be ...
Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...
The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.
For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...
Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...
SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.
City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...
Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...
Under the terms of the option agreement, which was signed in December 2024, Bausch + Lomb has secured the exclusive option to acquire InflammX Therapeutics during an agreed-upon option period based on ...